B-cell prolymphocytic leukemia with P53 abnormalities successfully treated with bendamustine and rituximab: a report of three cases

BACKGROUND: B-cell prolymphocytic leukemia (B-PLL) is a rare mature B-cell tumor with an aggressive clinical course and poor prognosis. It is characterized by prominent splenomegaly and prolymphocytes exceeding 55% of the lymphoid cells in the blood. Purine analog-based chemo-immunotherapy is the fi...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Anna, Guo, Wei, Damiani, Daniela, Sumbly, Vikram, Goyal, Gaurav, Du, Zhonghua, Bai, Ou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10425637/
https://www.ncbi.nlm.nih.gov/pubmed/37588745
http://dx.doi.org/10.21037/tcr-23-828

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10425637/
https://www.ncbi.nlm.nih.gov/pubmed/37588745
http://dx.doi.org/10.21037/tcr-23-828

Ejemplares similares